|
Stephen M. Elliston joined Advanced Viral Research Corp. on May 15 2006 as President and Chief Executive Officer. With over 25 years experience within the biopharmaceutical industry Mr. Elliston brings a wealth of experience to the company in virtually every facet of the business. During the course of his career he has held senior managerial positions in companies such as Schering-Plough Lederle Abbott Labs and Burroughs-Wellcome. In addition Mr. Elliston also served as President and CEO of Micrologix Biotech a publicly traded company based in Vancouver Canada. In this capacity he built a fully integrated R&D company based upon an early stage technology he had in-licensed from the University of British Columbia . Subsequent to this he also played an integral role in the early stage development of Merix Bioscience (now Argos Therapeutics) a Durham North Carolina based company with a primary focus in the field of therapeutic cancer vaccines. | 